Skip to main
MEDP

Medpace Holdings (MEDP) Stock Forecast & Price Target

Medpace Holdings (MEDP) Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 0%
Buy 9%
Hold 64%
Sell 9%
Strong Sell 18%

Bulls say

Medpace Holdings is projected to experience a significant increase in passthrough revenues, citing an anticipated rise of 200-300 basis points in the second half of the year compared to the elevated levels seen in the second quarter. The company has also reported a strong first quarter, marked by a higher volume of request for proposals (RFP), which indicates increasing demand for its services. Furthermore, Medpace expects its book-to-bill ratio to surpass 1.15x in the third quarter, reflecting robust business growth and operational strength.

Bears say

Medpace Holdings has experienced consistent backlog cancellations that have remained at or above the upper range of what the company deems acceptable, although they recently dropped toward the lower end of that range in Q2. The company's inability to quantify potential growth in Direct Service revenue raises concerns about future cash flows, despite a lack of expected significant decline by 2026. Adjusted EBITDA estimates for 2025 and 2026 have been revised upward, but these adjustments reflect increased direct service costs due to continued hiring, coupled with anticipated reductions in passthrough revenue, signaling underlying financial pressures.

Medpace Holdings (MEDP) has been analyzed by 11 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 9% recommend Buy, 64% suggest Holding, 9% advise Selling, and 18% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medpace Holdings (MEDP) Forecast

Analysts have given Medpace Holdings (MEDP) a Hold based on their latest research and market trends.

According to 11 analysts, Medpace Holdings (MEDP) has a Hold consensus rating as of Jan 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $479.64, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $479.64, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medpace Holdings (MEDP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.